![](/img/cover-not-exists.png)
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
Celestia S. Higano, Paul F. Schellhammer, Eric J. Small, Patrick A. Burch, John Nemunaitis, Lianng Yuh, Nicole Provost, Mark W. FrohlichVolume:
115
Year:
2009
Language:
english
Pages:
10
DOI:
10.1002/cncr.24429
File:
PDF, 402 KB
english, 2009